Extraordinary General Meeting of BioGaia

At an extraordinary general meeting of BioGaia AB (publ) on 22 August 2025, it was resolved to elect Mauricio Graber as new board member and chairman of the board, following Peter Rothschild’s decision to resign as board member and chairman.

Follow us:
Subscribe to BioGaia press releases here
LinkedIn here

Contacts:
Theresa Agnew, President and CEO
Email: [email protected]
Phone: +46(0)8 555 293 00

Alexander Kotsinas, CFO
Email: [email protected]
Phone: +46 735 00 11 11

About BioGaia
BioGaia is a Swedish probiotics company that has been at the forefront of microbiome research for more than 35 years. BioGaia develops, markets, and sells probiotic products focused on gut health, immune health, and oral health. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaiagroup.com